Top 10: Digital Diagnostics Platforms
The way diseases are detected and managed can be an arduous process, but with digital diagnostics platforms, it’s getting a lot quicker to complete and return results to anxious patients.
Digital diagnostics platforms harness the power of AI and advanced imaging techniques to enhance diagnostic accuracy, streamline workflows and improve patient outcomes. From early detection of diabetic retinopathy to comprehensive genomic analysis, companies like Digital Diagnostics, Philips and DeepMind Health are leading the charge in revolutionising medical diagnostics.
This article explores the Top 10 digital diagnostics platforms that are reshaping the future of healthcare, highlighting their unique contributions and the potential impact they hold for patients and providers alike.
10. MediWhale
Founded: 2016
Headquarters: Seoul, South Korea
CEO: Kevin Choi
MediWhale is a medical AI company specialising in retinal imaging analysis. Their flagship product, RETI-Intelligence, uses deep learning algorithms to analyse retinal images for the detection of various systemic diseases, including cardiovascular risk and cognitive impairment.
MediWhale's technology has shown promise in early disease detection and risk stratification. The company's approach to using retinal imaging as a non-invasive biomarker for systemic health has garnered attention in the medical community and has the potential to revolutionise preventive healthcare and early disease intervention.
9. AEYE Health
Founded: 2018
Headquarters: New York, US
CEO: Zack Dvey-Aharon
AEYE Health focuses on developing AI-powered retinal screening solutions for the early detection of eye diseases and systemic conditions. Their technology aims to make retinal screening more accessible and efficient, particularly in primary care settings. AEYE Health's AI algorithms have shown promising results in detecting diabetic retinopathy and other retinal pathologies.
The company has received FDA clearance for its diabetic retinopathy screening solution, demonstrating its potential to improve early disease detection and prevent vision loss in diabetic patients.
8. Digital Diagnostics (formerly IDx Technologies)
Founded: 2010
Headquarters: Iowa, US
CEO: John Bertrand
Digital Diagnostics is a pioneer in autonomous AI diagnostics. Their flagship product, IDx-DR, was the first FDA-cleared AI-based diagnostic system for the autonomous detection of diabetic retinopathy. The company aims to transform the quality, accessibility, and affordability of healthcare through AI-enabled diagnostic technology.
IDx-DR has demonstrated high accuracy, with 87% sensitivity and 90% specificity for detecting more than mild diabetic retinopathy. Digital Diagnostics continues to expand its portfolio of AI diagnostic solutions, focusing on democratising healthcare access and improving patient outcomes through early disease detection.
7. Kheiron Medical
Founded: 2016
Headquarters: London, UK
CEO: Dr. Peter Kecskemethy
Kheiron Medical Technologies specialises in developing AI solutions for breast cancer screening. Their flagship product, Mia (Mammography Intelligent Assessment), is designed to support radiologists in the early detection of breast cancer. Mia has shown promising results in clinical studies, demonstrating non-inferior performance to human readers in double-reading breast cancer screening workflows.
In one study, Mia achieved an area under the receiver operating characteristic curve (AUC) of 0.89 for cancer detection, comparable to expert radiologists. Kheiron's technology aims to improve the accuracy and efficiency of breast cancer screening programmes worldwide.
6. Skin Analytics
Founded: 2012
Headquarters: London, UK
CEO: Neil Daly
Skin Analytics is a pioneering company using advanced AI algorithms to detect skin cancer. Their flagship product, DERM, is a UKCA Class IIa AI as a Medical Device (AIaMD) for assessing skin lesions. Since 2020, Skin Analytics has assessed over 120,000 NHS patients for suspicion of skin cancer, helping secondary care organisations remove the need for up to 95% of face-to-face urgent suspected skin cancer appointments.
DERM has demonstrated high accuracy, with a malignancy sensitivity of over 97% in recent performance reports. The company has launched 24 partnerships with the NHS since 2020, significantly impacting early skin cancer detection and diagnosis.
5. RetinAI
Founded: 2016
Headquarters: Bern, Switzerland
CEO: Carlos Ciller
RetinAI is a Swiss company specialising in AI-powered retinal image analysis. Their platform provides automated analysis of various retinal imaging modalities, including fundus photography and optical coherence tomography (OCT). RetinAI's solutions aim to assist ophthalmologists in diagnosing and monitoring retinal diseases such as age-related macular degeneration and diabetic retinopathy.
The company has secured partnerships with major ophthalmic device manufacturers and research institutions, indicating the potential impact of their technology on improving eye care diagnostics and treatment planning.
4. Sciensus
Founded: 1992
Headquarters: London, UK
CEO: Darryn Gibson
Sciensus is a leading pharmaceutical services company which has developed a robust digital diagnostics platform as part of its commitment to improving patient care and treatment management. Their digital solutions include the Sciensus Intouch app, which allows patients to track prescriptions and connect with online communities.
Additionally, Sciensus Connect, a platform developed in collaboration with the NHS, provides healthcare professionals real-time access to patient records and medication information. These digital tools enable more efficient prescription management, improved communication between patients and providers and enhanced monitoring of treatment progress. Sciensus continues to invest in digital innovations to streamline healthcare delivery and improve patient outcomes.
3. Lifebit AI
Founded: 2017
Headquarters: London, UK
CEO: Dr. Maria Chatzou Dunford
Lifebit AI is a cloud-based AI-powered genomics platform that enables secure, scalable analysis of genomic and health data. The company's technology allows organisations to perform complex genomic analyses while ensuring data privacy and security. Lifebit's federated approach to data analysis has made it particularly attractive to large-scale genomics projects and biobanks.
While specific performance statistics are not publicly available, Lifebit has secured partnerships with major institutions and government bodies, including Genomics England and the Hong Kong Genome Project, demonstrating the platform's capabilities and potential impact on precision medicine and drug discovery.
2. DeepMind Health
Founded: 2010
Headquarters: US
CEO: Demis Hassabis
Revenue: US$307bn (Google Health)
DeepMind Health was integrated into Google Health in 2018. The company is at the forefront of applying AI to healthcare challenges. Their work includes developing AI models for medical imaging analysis, predicting patient deterioration and supporting clinical decision-making.
One notable achievement is their AI system for breast cancer screening, which demonstrated performance on par with human experts, reducing false positives by 5.7% and false negatives by 9.4% in one study. DeepMind Health's collaborations with healthcare institutions worldwide continue to push the boundaries of AI applications in medicine.
1. Philips
Founded: 1891
Headquarters: Netherlands
CEO: Roy Jakobs
Revenue: US$19.2bn
Founded in 1891 in Eindhoven, the Netherlands, by father and son Frederik and Gerard Philips, the company helped introduce electrical products to consumers and has grown to become a global leader in health technology. Philips offers a wide range of innovative solutions across the health continuum and its digital diagnostics platforms includes advanced imaging systems, AI-powered clinical decision support tools and integrated diagnostic solutions.
“Philips has built leading market positions based on meaningful innovations and high customer intimacy, further supported by a compelling purpose, a strong brand, and clear ESG commitments,” said CEO Roy Jakobs.
Philips' IntelliSite Pathology Solution, for instance, is a digital pathology platform that enables efficient workflow and collaboration among pathologists. The company's AI-enabled diagnostic imaging solutions have shown significant improvements in workflow efficiency and diagnostic accuracy across various medical specialties.
Make sure you check out the latest industry news and insights at Healthcare Digital and also sign up to our global conference series - Healthcare LIVE 2025
Healthcare Digital is a BizClik brand
